(Q37263684)

19 August 2017

1 reference

title

Dementia prevention: methodological explanations for inconsistent results (English)

1 reference

19 August 2017

0 references

1 reference

6

Bruno Vellas

1 reference

19 August 2017

Nicola Coley

1

1 reference

19 August 2017

Sandrine Andrieu

2

1 reference

19 August 2017

Virginie Gardette

3

1 reference

19 August 2017

Sophie Gillette-Guyonnet

4

1 reference

19 August 2017

Caroline Sanz

5

1 reference

19 August 2017

Alain Grand

7

1 reference

19 August 2017

publication date

8 September 2008

1 reference

19 August 2017

published in

Epidemiologic Reviews

1 reference

19 August 2017

volume

30

1 reference

19 August 2017

page(s)

35-66

1 reference

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Homocysteine and cognitive decline in healthy elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Plasma homocysteine levels and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Vitamin B(12) and folate in relation to the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Relation of higher folate intake to lower risk of Alzheimer disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Prospective study of plasma folate, vitamin B12, and cognitive function and decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Intake of flavonoids and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Flavonoid intake and cognitive decline over a 10-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Is antioxidant use protective of cognitive function in the community-dwelling elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Plasma selenium over time and cognitive decline in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Plasma carotenoids and tocopherols and cognitive function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary fats and the risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary patterns and risk of dementia: the Three-City cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Mediterranean diet and risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Fish, meat, and risk of dementia: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Fish consumption and cognitive decline with age in a large community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A controlled trial of homocysteine lowering and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A randomized trial of vitamin E supplementation and cognitive function in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

An active and socially integrated lifestyle in late life might protect against dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Influence of leisure activity on the incidence of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Marital status and risk of Alzheimer's disease: a French population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Women who maintain optimal cognitive function into old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Social resources and cognitive decline in a population of older African Americans and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Trajectories of cognitive decline and social relations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Engaged lifestyle and cognitive function in middle and old-aged, non-demented persons: a reciprocal association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Social network characteristics and cognition in middle-aged and older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Leisure activity and risk of cognitive impairment: the Chongqing aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The relation between everyday activities and successful aging: a 6-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Leisure activities and the risk of dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Relation of cognitive activity to risk of developing Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Leisure activities and the risk of amnestic mild cognitive impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Cognitive activity and cognitive decline in a biracial community population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Walking and dementia in physically capable elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity and risk of cognitive impairment and dementia in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity in relation to cognitive decline in elderly men: the FINE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Exercise level and cognitive decline: the MoVIES project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Does active leisure protect cognition? Evidence from a national birth cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity and the risk of dementia in oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity, including walking, and cognitive function in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A prospective study of physical activity and cognitive decline in elderly women: women who walk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Social and leisure activities and risk of dementia: a prospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Physical activity, cognitive activity, and cognitive decline in a biracial community population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Does activity engagement protect against cognitive decline in old age? Methodological and analytical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Activity in older adults: cause or consequence of cognitive functioning? A longitudinal study on everyday activities and cognitive performance in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effects of multifactorial memory training in old age: generalizability across tasks and individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Transfer of a speed of processing intervention to near and far cognitive functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Long-term effects of cognitive training on everyday functional outcomes in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The effect of two types of memory training on subjective and objective memory performance in healthy individuals aged 55 years and older: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hormone replacement therapy and cognition: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hormone replacement therapy and cognitive performance in postmenopausal women--a review by cognitive domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The menopause and HRT. HRT and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen and Cognitive Functioning in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen replacement therapy and cognitive decline in older community women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Postmenopausal hormone therapy and cognitive function in healthy older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Insulin-like growth factor I and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The influence of hormone replacement therapy on the aging-related change in cognitive performance. Analysis based on a Danish cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effects of hormone replacement therapy on cognitive performance in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The effect of hormone replacement on physical performance in community-dwelling elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Association between hormone replacement therapy and dementia: is it time to forget?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Aspirin use and cognitive function in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Does NSAID use modify cognitive trajectories in the elderly? The Cache County study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Low dose aspirin and cognitive function in the women's health study cognitive cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The age-dependent relation of blood pressure to cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Age-Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community-Based Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hypertension and the risk of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hypertension and changes of cognitive function in 81-year-old men: a 13-year follow-up of the population study "Men born in 1914", Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Relationship of race/ethnicity and blood pressure to change in cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Current and remote blood pressure and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Low blood pressure and the risk of dementia in very old individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Developmental and vascular risk factors for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Vascular risks and incident dementia: results from a cohort study of the very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risk factors for dementia in the cardiovascular health cognition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Blood pressure and late-life cognitive function change: a biracial longitudinal population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Vascular risk factors, incidence of MCI, and rates of progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Relationship between blood pressure and Alzheimer's disease in Linxian County, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The association between low diastolic blood pressure in middle age and cognitive function in old age. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Long-term effects of childhood obesity on morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Aggregation of vascular risk factors and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes mellitus in midlife and the risk of dementia three decades later

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Premenopausal determinants of menopausal estrogen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXN010

21 January 2018

Identifiers

DOI

10.1093/EPIREV/MXN010

1 reference

19 August 2017

1 reference